PW MEDTECH GROUP LIMITED (01358.HK): Expected H1 Net Profit Drop of 43%‑63%

NewTimeSpace News: On 10 August 2026, PW MEDTECH GROUP LIMITED (01358.HK) issued a profit warning. Based on preliminary review of the unaudited consolidated management accounts, the Group expects to record a net profit of approximately RMB32 million to RMB49 million for the first half‑year, down 43%‑63% from about RMB86.6 million for the corresponding period of last year. Profit attributable to owners of the Company is estimated at RMB13 million to RMB20 million, a decrease of 70%‑80% compared with RMB66 million in the prior‑year same period.

According to the announcement, the performance decline is mainly driven by the nearly full implementation of the volume‑based centralized procurement policy for the infusion set business segment. The policy covers Beijing and other regions which account for a large proportion of segment sales, triggering substantial product price cuts and resulting in notable drops in sales revenue and gross profit margin.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.